Author Archive: Stephanie Fischer

Stephanie Fischer

I am the Director of Communications for health and intellectual property issues at BIO.  Prior to joining BIO, I served as Communications Director for Rep. Jim Greenwood (R-PA), my hometown Congressman from Bucks County, Pennsylvania.  One of my favorite things about working at BIO is how smart my colleagues are and how willing they are to educate me (and the media) about the science of biotechnology as well as the regulatory framework in which our companies operate. Outside of work, I enjoy reading, baking and travelling (especially to the beach).  I am known among friends for finding good deals online (and within BIO for getting a lot of packages)!

Latest Posts

Importance of Reauthorizing Pandemic All-Hazards Preparedness Act

Sen. Casey

Senator Robert P. Casey, Jr. (D-PA) joined with BIO and The Center for Biosecurity of UPMC to co-sponsor a Hill briefing on the reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA) on March 1st.  Officials from the Food and Drug Administration, Centers for Disease Control and Prevention, the White House, and Department of Health and Human Services as well as experts from the Center for Biosecurity at UPMC and the WMD Center discussed the critical Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,

IPCC Features Update on Patent Reform Implementation

Gongola_Janet

The BIO Intellectual Property Counsels Committee Fall Conference featured an update on the implementation of the Leahy-Smith America Invents Act by Janet Gongola, Associate Solicitor of the U.S. Patent and Trademark Office (PTO). Some provisions of the Leahy-Smith America Invents Act took effect immediately when it was signed into law in September. Ms. Gongola reported that of the 20 provisions that must be implemented by the PTO, eight have been implemented and another ten are Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

The Critical Importance of International Patent Protection for Small Businesses

Stanley Erck

As part of the implementation of the Leahy-Smith America Invents Act, the U.S. Patent and Trademark Office (PTO) recently held two public hearing on international patent protection.  Stanley C. Erck, President and CEO of Novavax, Inc., testified on behalf of BIO in support of an initiative to reduce filing and prosecution costs for international patent protection of biotech inventions. In his testimony, Mr. Erck explained the important role patents play in the biotechnology industry. The Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

KORUS and BIO’s New Senior Vice President for International Affairs

Joseph Damond

Earlier this week, Joseph Damond joined BIO as Senior Vice President of International Affairs.  He brings extensive experience in international affairs, trade and economics, most recently serving as Vice President of International Government Relations at Pfizer, Inc.  He previously served as Deputy Vice President for International Affairs at PhRMA and as the Deputy Assistant for the Asia-Pacific region in the Office of the U.S. Trade Representative. Joe will spearhead BIO’s international trade policy and help Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Patent Reform Inches Closer to Becoming Law

Credits: house.gov

Yesterday, Senate Majority Leader Harry Reid (D-NV) filed for cloture for The Leahy-Smith America Invents Act, H.R. 1249, bringing it one step closer to becoming law.  When the Senate reconvenes in September, patent reform will be at the top of the agenda. In his comments on the Congressional compromise on the debt ceiling, President Obama included patent reform in the list of action needed to stimulate the economy and create jobs: “Through patent reform, we Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , ,